| Literature DB >> 33098388 |
Pinar Gulsen Coban1, Ayla Sargin Oruc2, Meryem Kuru Pekcan3, Hasan Ali Inal4, Necati Hancerliogullari3, Nafiye Yilmaz3.
Abstract
BACKGROUND: We investigated the impact of the choice of catheter type and tenaculum use on pregnancy related outcomes in intrauterine insemination (IUI) treatments.Entities:
Keywords: Catheter; Clinical Pregnancy Rate; Intrauterine Insemination; Live Birth Rate; Tenaculum
Year: 2020 PMID: 33098388 PMCID: PMC7604713 DOI: 10.22074/ijfs.2020.6161
Source DB: PubMed Journal: Int J Fertil Steril ISSN: 2008-0778
Fig.1Enrollement and follow-up of the study subjects.
Fig.2Perinatal outcomes of the groups. Group 1; Soft, Group 2; Firm, and Group 3; Tenaculum.
Demographic characteristics and laboratory parameters of the patients
| Group 1 Soft (n=175) | Group 2 Firm (n=100) | Group 3 Tenaculum (n=63) | p | ||
|---|---|---|---|---|---|
| Age (Y) | 26.53 ± 4.51 | 27.05 ± 4.98 | 27.97 ± 4.33 | 0.103a | |
| BMI (kg/m2) | 25.05 ± 3.46 | 24.66 ± 3.44 | 24.05 ± 3.19 | 0.135a | |
| Primary infertility (%) | 126 (72.0) | 80 (80.0) | 48 (76.2) | 0.322 | |
| Secondary infertility (%) | 49 (28.0) | 20 (20.0) | 15 (23.8) | ||
| Duration of infertility (Y) | 3 (1-12) | 3 (1-14) | 3 (1-16) | 0.589b | |
| Baseline FSH (IU/L) | 6.78 ± 1.72 | 7.01 ± 1.88 | 6.44 ± 1.35 | 0.120a | |
| Baseline LH (IU/L) | 4.51 ± 1.56 | 4.77 ± 1.75 | 4.66 ± 1.85 | 0.454a | |
| Baseline E2 (pg/mL) | 41.21 ± 17.50 | 40.52 ± 14.04 | 41.19 ± 16.16 | 0.941a | |
| Antral follicle count | 10 (6-16) | 10 (7-16) | 10 (4-16) | 0.115b | |
| hMG(%) | 85 (48.6) | 45 (45.0) | 23 (36.5) | 0.165 | |
| rFSH (%) | 90 (51.4) | 55 (55.0) | 40 (63.5) | ||
| Duration of stimulation (D) | 5 (5-16) | 5 (5-13) | 5 (5-16) | 0.478b | |
| rFSH dose (IU) | 75 (37.5-225) | 75 (37.5-187.5) | 75 (37.5-112.5) | 0.522b | |
| hMG dose (IU) | 112.5 (75-150) | 150 (75-225) | 75 (75-225) | 0.251b | |
| Number of cycle | 2 (1-5) | 2 (1-5) | 2 (1-5) | 0.723b | |
| Number of >17 mm follicles | 1 (1-3) | 1 (1-4) | 1 (1-3) | 0.763b | |
| Trigger | Pregnyl (%) | 151 (86.3) | 81 (81.0) | 54 (85.7) | 0.498 |
| Ovitrelle (%) | 24 (13.7) | 19 (19.0) | 9 (14.3) | ||
| E2 on hCG administration day (pg/mL) | 398.54 ± 154.85 | 338.13 ± 15.01 | 537.92 ± 375.66 | 0.196a | |
| TPMSC (x106) | 51.37 ± 22.17 | 53.35 ± 25.78 | 52.62 ± 25.57 | 0.801a | |
| Morphology | 6.94 ± 1.77 | 7.04 ± 1.60 | 6.98 ± 1.70 | 0.903a | |
| Endometrial thickness on hCG day (mm) | 8.94 ± 1.73 | 8.96 ± 1.72 | 9.02 ± 1.82 | 0.954a | |
| Trilaminer sign (%) | 159 (90.9) | 94 (94.0) | 56 (88.9) | 0.476 | |
| Luteal phase support (%) | 38 (21.7) | 26 (26.0) | 21 (33.3) | 0.194 | |
Data are presented as mean ± SD or n(%). SD; Standard deviation, a; One-way ANOVA test, b; Kruskal Wallis test, BMI; Body mass index, FSH; Follicle stimulan hormone, LH; Luteinizan hormone, E2: Estradiol, hMG; Human menopausal gonadotropine, hCG; Human corionic gonadotropine, and TPMSC; Total progressive motile sperm count. P<0.05 is statistical significant.
Pregnancy related outcomes of soft, firm catheter and tenaculum applied patients undergoing IUI treatment
| Group 1 Soft (n=175) | Group 2 Firm (n=100) | Group 3 Tenaculum (n=63) | P value | |
|---|---|---|---|---|
| Clinical pregnancy rate) | 5.1 (9/175)a, b | 19 (19/100)a | 31.7 (20/63)b | <0.001* |
| Miscarriage rate/clinical pregnancy | 22.2 (2/9) | 15.8 (3/19) | 20.0 (4/20) | 0.736 |
| Live birth rate/clinical pregnancy | 77.8 (7/9) | 84.2 (16/19) | 80.0 (16/20) | |
Data are presented as n (%). *; Statistically significant, IUI; Intrauterine insemination, a; Group 1 versus Group 2, and b; Group 1 versus 3.